Document Detail

Vitiligo: recent insights and new therapeutic approaches.
MedLine Citation:
PMID:  23149710     Owner:  NLM     Status:  Publisher    
Vitiligo represents a selective destruction of the melanocytes. It is a relatively common, probably autoimmune disorder that affects people of all backgrounds and both genders. No particular group seems to be preferentially affected. Half of vitiligo patients have an onset before the age of 18 years. In regions where leprosy is endemic, individuals with vitiligo are often stigmatized due to similarities in appearance between the two diseases. We will review this important subject, emphasizing the latest therapeutic advances.
T M Lotti; S F Berti; J Hercogova; R H Huggins; B W Lee; C K Janniger; R A Schwartz
Publication Detail:
Journal Detail:
Title:  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia     Volume:  147     ISSN:  0392-0488     ISO Abbreviation:  G Ital Dermatol Venereol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102852     Medline TA:  G Ital Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  637-647     Citation Subset:  -    
Dermatology and Venereology, University "G. Marconi", Rome, Italy -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Skin diseases in geriatric patients: our experience from a public skin outpatient clinic in Siena.
Next Document:  Appearance of a reservoir of hookworm-related cutaneous larva migrans in Brittany?